Immuneering (IMRX) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Immuneering Corporation  (NASDAQ: IMRX)


Immuneering's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMRX Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Learn about Gross Margin
IMRX's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
100 % 56.17 % 45.31 %
(Dec 31 2022)   (Mar 31 2021)


IMRX Gross Income Trends • More of IMRX's Profitabilty Ratios • IMRX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
IMRX's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
IMRX's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for IMRX's Competitors
Gross Profit Margin Profit Margin for Immuneering's Suppliers
Gross Profit Margin Profit Margin for IMRX's Customers

You may also want to know
IMRX's Annual Growth Rates IMRX's Profitability Ratios IMRX's Asset Turnover Ratio IMRX's Dividend Growth
IMRX's Roe IMRX's Valuation Ratios IMRX's Financial Strength Ratios IMRX's Gross Profit Growth
IMRX's Roa IMRX's Inventory Turnover Ratio IMRX's Growth Rates IMRX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.